FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Repromed Fertility Center, Karl Storz GmbH, and Voss Plastics.

FDA Proposes Rule on E-prescribing Information

[ Price : $8.95]

FDA issues a proposed rule to require electronic distribution of the prescribing information intended for health care professional...

Maisel Lists CDRH Strategic Priorities

[ Price : $8.95]

CDRH deputy director for science William Maisel says the Center is working to ensure that U.S. patients are the first in the world...

Patient Voices Introduce Bias: Commentator

[ Price : $8.95]

Drug industry commentator David Grainger says listening to patient advocacy groups can bring a bias into healthcare decision-makin...

FDA Clears Bovie Medical Surgical Generator

[ Price : $8.95]

FDA clears a Bovie Medical 510(k) for its Bovie Ultimate generator, a high-frequency electrosurgical generator that can be used fo...

Voss Plastics Warned About QS Violations

[ Price : $8.95]

FDAs Dallas District Office warns Voss Plastics about Quality System and Medical Device Reporting violations in its manufacturing ...

QS Violations Found in Karl Storz Endovision

[ Price : $8.95]

FDAs New England District Office warns Karl Storz Endovision about Quality System violations at its Charlton, MA, production facil...

DoJ Nixes Prosecution of Pair Who Used Unapproved Drugs in Practice

[ Price : $8.95]

The U.S. Justice Department drops a case against physician Anindya Kumar Sen and his wife and practice manager Patricia Posey Sen ...

2 Innovations Can Change Drug Production: Consultants

[ Price : $8.95]

Consultants Marcus Ehrhardt and Peter Behner say two drug production innovations will significantly change the currently stagnant ...

Point-of-Care Communication Channel Growing: Consultants

[ Price : $8.95]

A ZS Associates study says point-of-care communications is growing much faster than overall direct-to-consumer communications.